Tillman U. Gerngross - Net Worth and Insider Trading
Tillman U. Gerngross Net Worth
The estimated net worth of Tillman U. Gerngross is at least $383,472 dollars as of 2024-05-16. Tillman U. Gerngross is the Director of X4 Pharmaceuticals Inc and owns about 392,821 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $383,472. Details can be seen in Tillman U. Gerngross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tillman U. Gerngross has not made any transactions after 2017-11-20 and currently still holds the listed stock(s).
Transaction Summary of Tillman U. Gerngross
Tillman U. Gerngross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tillman U. Gerngross owns 3 companies in total, including Alector Inc (ALEC) , X4 Pharmaceuticals Inc (XFOR) , and Invivyd Inc (IVVD) .
Click here to see the complete history of Tillman U. Gerngross’s form 4 insider trades.
Insider Ownership Summary of Tillman U. Gerngross
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALEC | Alector Inc | 2023-06-14 | director |
| XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | director & 10 percent owner |
| IVVD | Invivyd Inc | 2021-08-05 | director & 10 percent owner & Chief Executive Officer |
Tillman U. Gerngross Latest Holdings Summary
Tillman U. Gerngross currently owns a total of 1 stock. Tillman U. Gerngross owns 392,821 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $383,472.
Latest Holdings of Tillman U. Gerngross
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 392,821 | 0.98 | 383,472 |
Holding Weightings of Tillman U. Gerngross
Tillman U. Gerngross Form 4 Trading Tracker
According to the SEC Form 4 filings, Tillman U. Gerngross has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 200,000 shares on November 20, 2017, which cost Tillman U. Gerngross around $2 Million.
Insider Trading History of Tillman U. Gerngross
- 1
Tillman U. Gerngross Trading Performance
GuruFocus tracks the stock performance after each of Tillman U. Gerngross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tillman U. Gerngross is 0.28%. GuruFocus also compares Tillman U. Gerngross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tillman U. Gerngross within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tillman U. Gerngross's insider trading performs compared to the benchmark.
Performance of Tillman U. Gerngross
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.97 | | | | | |
| Relative Return to S&P 500(%) | -17.73 | | | | | |
Tillman U. Gerngross Ownership Network
Tillman U. Gerngross Owned Company Details
What does Alector Inc do?
Who are the key executives at Alector Inc?
Tillman U. Gerngross is the director of Alector Inc. Other key executives at Alector Inc include President and Head of R&D Sara Kenkare-mitra , Chief Medical Officer Gary Romano , and director & Chief Executive Officer Arnon Rosenthal .
Alector Inc (ALEC) Insider Trades Summary
Over the past 18 months, Tillman U. Gerngross made no insider transaction in Alector Inc (ALEC). Other recent insider transactions involving Alector Inc (ALEC) include a net sale of 74,605 shares made by Arnon Rosenthal , a net sale of 43,118 shares made by Sara Kenkare-mitra , and a net sale of 21,807 shares made by Gary Romano .
In summary, during the past 3 months, insiders sold 40,723 shares of Alector Inc (ALEC) in total and bought 0 shares, with a net sale of 40,723 shares. During the past 18 months, 1,153,275 shares of Alector Inc (ALEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,153,275 shares.
Alector Inc (ALEC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alector Inc Insider Transactions
Tillman U. Gerngross Mailing Address
Above is the net worth, insider trading, and ownership report for Tillman U. Gerngross. You might contact Tillman U. Gerngross via mailing address: C/o Arsanis, Inc., 890 Winter Street, Suite 230, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
